Gene · 54894
Papers2,200
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,200
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Somatic mutations can induce a noninflamed tumour microenvironment via their original gene functions, despite deriving neoantigens. | Br J Cancer | 2023 | 36732592 | PubTator, text mining | PubMed |
| ScRNA-seq and ST-seq in liver research. | Cell Regen | 2023 | 36732412 | PubTator, text mining | PubMed |
| The genetic profile and molecular subtypes of human pseudomyxoma peritonei and appendiceal mucinous neoplasms: a systematic review. | Cancer Metastasis Rev | 2023 | 36723696 | PubTator, text mining | PubMed |
| Evaluation of inherited germline mutations in cancer susceptibility genes among pancreatic cancer patients: a single-center study. | Mol Med | 2023 | 36717774 | PubTator, text mining | PubMed |
| WNT Pathway Mutations in Metachronous Oligometastatic Castration-Sensitive Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2023 | 36708787 | PubTator, text mining | PubMed |
| The complementary roles of genome-wide approaches in identifying genes linked to an inherited risk of colorectal cancer. | Hered Cancer Clin Pract | 2023 | 36707860 | PubTator, text mining | PubMed |
| The clinical and genomic distinctions of Class1/2/3 BRAF-mutant colorectal cancer and differential prognoses. | Biomark Res | 2023 | 36694231 | PubTator, text mining | PubMed |
| Protein degradation: expanding the toolbox to restrain cancer drug resistance. | J Hematol Oncol | 2023 | 36694209 | PubTator, text mining | PubMed |
| Genomic landscape of 891 RET fusions detected across diverse solid tumor types. | NPJ Precis Oncol | 2023 | 36690680 | PubTator, text mining | PubMed |
| Local recurrence after successful endoscopic submucosal dissection for rectal mucinous mucosal adenocarcinoma: A case report. | World J Gastrointest Oncol | 2023 | 36684048 | PubTator, text mining | PubMed |
| CDK1 bridges NF-κB and β-catenin signaling in response to H. pylori infection in gastric tumorigenesis. | Cell Rep | 2023 | 36681899 | PubTator, text mining | PubMed |
| Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study. | Lancet Oncol | 2023 | 36681091 | PubTator, text mining | PubMed |
| The Somatic Mutational Landscape of Mismatch Repair Deficient Prostate Cancer. | J Clin Med | 2023 | 36675550 | PubTator, text mining | PubMed |
| Molecular Mechanisms in Genetic Aortopathy-Signaling Pathways and Potential Interventions. | Int J Mol Sci | 2023 | 36675309 | PubTator, text mining | PubMed |
| Potential Involvement of LncRNAs in Cardiometabolic Diseases. | Genes (Basel) | 2023 | 36672953 | PubTator, text mining | PubMed |
| Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas. | Cancer Med | 2023 | 36670542 | PubTator, text mining | PubMed |
| Comprehensive ctDNA Measurements Improve Prediction of Clinical Outcomes and Enable Dynamic Tracking of Disease Progression in Advanced Pancreatic Cancer. | Clin Cancer Res | 2023 | 36662807 | PubTator, text mining | PubMed |
| Cancer Risk Associated With PTEN Pathogenic Variants Identified Using Multigene Hereditary Cancer Panel Testing. | JCO Precis Oncol | 2023 | 36634299 | PubTator, text mining | PubMed |
| Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers. | Nat Commun | 2023 | 36611031 | PubTator, text mining | PubMed |
| Transcriptional activity mediated by β-CATENIN and TCF/LEF family members is completely dispensable for survival and propagation of multiple human colorectal cancer cell lines. | Sci Rep | 2023 | 36609428 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54894/papers?page=24